Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 25:3:83-90.
doi: 10.1016/j.dadm.2016.06.004. eCollection 2016.

A blood screening test for Alzheimer's disease

Sid E O'Bryant  1 , Melissa Edwards  2 , Leigh Johnson  1 , James Hall  1 , Alcibiades E Villarreal  3 , Gabrielle B Britton  4 , Mary Quiceno  5 , C Munro Cullum  5 , Neill R Graff-Radford  6
Affiliations

A blood screening test for Alzheimer's disease

Sid E O'Bryant et al. Alzheimers Dement (Amst). .

Abstract

Introduction: This study combined data across four independent cohorts to examine the positive and negative predictive values of an Alzheimer's disease (AD) blood test if implemented in primary care.

Methods: Blood samples from 1329 subjects from multiple independent, multiethnic, community-based, and clinic-based cohorts were analyzed. A "locked-down" referent group of 1128 samples was generated with 201 samples randomly selected for validation purposes. Random forest analyses were used to create the AD blood screen. Positive (PPV) and negative (NPV) predictive values were calculated.

Results: In detecting AD, PPV was 0.81, and NPV was 0.95 while using the full AD blood test. When detecting mild cognitive impairment, PPV and NPV were 0.74 and 0.93, respectively. Preliminary analyses were conducted to detect any "neurodegenerative disease". The full 21-protein AD blood test yielded a PPV of 0.85 and NPV of 0.94.

Discussion: The present study creates the first-ever multiethnic referent sample that spans community-based and clinic-based populations for implementation of an AD blood screen.

Keywords: Alzheimer's disease; Blood test; Diagnosis; Predictive power; Primary care; Screening.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multistate diagnostic process for detecting Alzheimer's disease (AD) and discriminating AD from other dementias.
See this image and copyright information in PMC

References

    1. Alzheimer's Association 2008 Alzheimer's disease facts and figures. Alzheimers Dement. 2008;4:110–133. - PubMed
    1. Alzheimer's Association 2013 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 2013;9:1–72. - PubMed
    1. Hurd M.D., Martorell P., Delavande A., Mullen K.J., Langa K.M. Monetary costs of dementia in the United States. N Engl J Med. 2013;368:1326–1334. - PMC - PubMed
    1. The Gerontological Society of America . 2015. The Gerontological Society of America Workgroup on Cognitive Impairment Detection and Earlier Diagnosis: Report and Recommendations.
    1. Novak K. Alzheimer's Association; Chicago, IL: 2004. Hispanics/Latinos and Alzheimer's disease.